Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin vs Botox in Cervical Dystonia
NCT03905304Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Jan 2013
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial of Meditoxin in cervical dystonia (CD) (2 arms), sponsored by Medytox Inc. Primary endpoint: Toronto Western Spasmodic Torticollis Rating Scale at 1 month. Started Jan 2013; status: completed.
02
Drugs
Meditoxin
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT03905304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905304.